[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@PsychedStocks](/creator/twitter/PsychedStocks)
"$CYBN CYB003 Phase X data readout expected Q2 2025 Psychedelic therapies gaining momentum Investors anticipate regulatory advancements $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975634998087606558) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-07T18:51Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X depression trial nearing completion Primary endpoint data readout Q2 2025 Investor anticipation driving sector momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975701600757825886) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-07T23:15Z XXX followers, XXX engagements


"$CYBN 8-K reveals manufacturing partnership Scale-up capabilities secured for Phase X Commercial readiness progressing rapidly $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975885770536767890) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T11:27Z XXX followers, XXX engagements


"$CYBN Q3 cash burn reduced by XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975961656405504186) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T16:29Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975976124128588122) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T17:26Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976036207080427574) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T21:25Z XXX followers, XXX engagements


"$CYBN CYBN trading XXX% higher today Anticipation ahead of Q4 financial results Investor confidence in psychedelic milestones $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976262673944707311) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T12:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Depression trial progressing well with strong data Positioned for major regulatory conversations $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976277793668301276) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T13:25Z XXX followers, XX engagements


"$CYBN CYB003 Phase X trial completion announced Preparing for FDA End-of-Phase-2 meeting Advancing psilocybin treatment for depression $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976292940868681762) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T14:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment on track Psychedelic depression trial progressing well Regulatory approval efforts gaining momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976338232301265071) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T17:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X data scheduled for Q2 2025 Regulatory prep underway for FDA meeting Progress in psilocybin depression treatment $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976353266624614516) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T18:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976398557771903156) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T21:25Z XXX followers, XXX engagements


"$CYBN CYB004 Phase X fully enrolled for anxiety Expect data readout in Q2 2025 Solid positioning in the mental health sector $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976609999171293430) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T11:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X primary endpoint data Q2 2025 18-month cash runway extending strategic scope Early-stage sector ripe for transformative advances $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976655242746855440) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T14:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X depression trial hits primary endpoint Significant efficacy data supports upcoming FDA meeting Positioned as leader in psychedelic therapeutics $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976670411807945096) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T15:25Z XXX followers, XXX engagements


"$CYBN Strong momentum in CYB003 Phase X trial Patient enrollment nearing completion Advancing depression treatment breakthroughs $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976685529962791327) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T16:25Z XXX followers, XXX engagements


"$CYBN 8-K filing reveals manufacturing partnership Scale-up capabilities secured for Phase X Commercial readiness timeline accelerating $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976700681219166457) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T17:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977697135702213028) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T11:25Z XXX followers, XXX engagements


"$CYBN FDA acknowledges CYB003 breakthrough potential Strategic advancement in depression treatment Path towards Phase X trials accelerating $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1977712235100180781) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T12:25Z XXX followers, XXX engagements


"$CYBN CYB004 Phase X anxiety trial achieves full enrollment Strengthens multiple shots on goal strategy Psychedelic development gaining momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977727395340722256) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T13:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977742452984328456) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T14:25Z XXX followers, XXX engagements


"$CYBN CYB004 last patient dosed in anxiety trial Phase X fully enrolled data expected Q2 2025 Strategic focus on regulatory-ready pipeline $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1977772671329821149) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T16:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment complete Advancing psilocybin in depression treatment Clinical pathway progressing on schedule $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1977802838345441782) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T18:25Z XXX followers, XXX engagements


"$CYBN CYB004 anxiety trial Phase X fully enrolled Advancing pipeline with diverse clinical programs Strategic focus on expanding treatment reach $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977817959880941712) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T19:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X depression trial completed Primary endpoint data readout Q2 2025 Psychedelic treatment viability increasing $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977833033748119563) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T20:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X program progresses First patient dosed marking a key milestone Building momentum in psychedelic treatment $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978059505872040440) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T11:25Z XXX followers, XXX engagements


"$CYBN Manufacturing partnership boosts CYB003 Scale-up readiness for Phase X confirmed Accelerating path to market $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978074622424654235) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T12:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X interim data promising Psilocybin progressing depression treatment Unlocking potential for breakthrough therapy $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978089727732449389) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T13:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978104902300626953) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T14:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978119936296861838) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T15:25Z XXX followers, XXX engagements


"$SMH Semiconductors see pullback from recent highs Volume nearing 3x daily average activity Leverage magnifying sector volatility $NVDA $AMD $TSM $AVGO"  
[X Link](https://x.com/PsychedStocks/status/1978120216283332767) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T15:26Z XXX followers, XX engagements


"$CYBN CYB003 Phase X enrollment progressing Patient dosing in depression trial ongoing Psilocybin treatment seeing positive trends $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978135044217516485) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T16:25Z XXX followers, XXX engagements


"$SOXX Chip sector moves on semiconductor index loss Volume spike as traders reassess positions 3X leverage in play amid market shifts $NVDA $TSM $AVGO $AMD"  
[X Link](https://x.com/PsychedStocks/status/1978137062290129101) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T16:33Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X trial interim results announced Encouraging safety and efficacy data for depression Regulatory discussions anticipated next quarter $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978150109176086607) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T17:25Z XXX followers, XXX engagements


"$CYBN CYB003 trial achieves XX% enrollment milestone Progress in psilocybin depression treatment Pivotal data readout expected Q2 2025 $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978165232540192877) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T18:25Z XXX followers, XXX engagements


"$CYBN CYB003 trial progressing rapidly Phase X depression study XX% enrolled Strong regulatory path for psilocybin therapy $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978195432267231627) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T20:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978421875408519471) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T11:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment surpasses XX% Patient recruitment shows strong trial momentum Psychedelic treatment pipeline advancing rapidly $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978437026262200800) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T12:25Z XXX followers, XXX engagements


"$CYBN Investor spotlight on rising $CYBN share Approaches X% gain amid sector enthusiasm Key upcoming trial regulatory milestones in view $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978452118311776760) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T13:25Z XXX followers, XXX engagements


"$TLT Long bonds slightly up on economic concerns Volume aligns with typical trading range Consider leverage as yields shift dynamically $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978467445728760133) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T14:26Z XXX followers, XXX engagements


"$CYBN First patient dosed in CYB003 depression trial Positive momentum as trial progresses Psychedelic medicine gaining traction $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978482376150782029) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T15:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment update Patient dosing for depression advancing Therapeutic pipeline continuing momentum $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978497454573023429) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T16:25Z XXX followers, XXX engagements


"$TLT Long bonds nearing resistance levels Volume showing strength with increased activity Triple leverage can magnify these bond movements $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978501662416240739) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T16:42Z XXX followers, XXX engagements


"$TLT Long bonds selling off post-Fed minutes Volume surging to 2.5x daily average Consider implications in rising rate environment $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978518561531334915) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T17:49Z XXX followers, XXX engagements


"$TLT Long bonds rallying on dovish Fed speak Yields dropping as recession fears build Triple leverage on duration trade $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978535433890939248) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T18:56Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X progressing ahead of schedule Patient dosing accelerating in psilocybin depression trial Regulatory momentum building for breakthrough therapy $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978542860245893375) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T19:25Z XXX followers, XXX engagements


"$TLT Long bonds steady amid dovish Fed stance Volume aligns with average trading flow Leverage on bond duration opportunity $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978555912378781915) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T20:17Z XXX followers, XXX engagements


"$SOXX Semiconductors facing pressure today Volume approaching triple average levels Opportunity in pullback for leverage traders $NVDA $TSM $AVGO $AMD"  
[X Link](https://x.com/PsychedStocks/status/1978557718836187163) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T20:24Z XXX followers, XXX engagements


"$CYBN XXX% price gain on surging volume Psychedelic stocks attracting strong interest Depression treatment solutions gaining visibility $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978559052603900145) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T20:30Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X trial initiated ahead of plans Accelerating psilocybin depression program Potential market leadership opportunity $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978572925377634316) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T21:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on positive Q3 earnings Efficient capital use extends cash runway XX months Psychedelic market dynamics drive investor interest $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978784324959752435) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T11:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins Board to bolster defense strategies Targeting 140000 US defense contractors Revolutionizing CMMC compliance for SMEs $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978798377589424245) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T12:21Z XXX followers, XX engagements


"$CYBN CYB003 Phase X interim safety data positive Shares up nearly X% on clinical progress Psilocybin therapies gaining traction $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978799427126009933) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T12:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Executes major deal with U.S. government Targeting $1B defense market opportunity Transforming SME cybersecurity landscape $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978813449959280987) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T13:21Z XXX followers, XX engagements


"$CYBN CYB003 Phase X primary endpoint readout released Data supports advancement to Phase X trials Strengthens position in psilocybin depression treatment $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978814549697392754) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T13:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins Board - bolstering defense focus Addressing $1B market opportunity with swift compliance Disrupting cybersecurity with AI-driven solutions $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978828566486798580) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T14:21Z XXX followers, XX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978829686416289930) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T14:25Z XXX followers, XXX engagements


"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978844800422908082) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T15:25Z XXX followers, XXX engagements


"$CYBN CYB003 enrollment nears XX% completion Psilocybin depression trial gains momentum Positive vibes in psychedelic sector $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978859804371132741) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T16:25Z XXX followers, XXX engagements


"$CYBN Trading stabilizing post market volatility Investor interest in pipeline developments Focus remains on clinical milestones ahead $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978874930205749393) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T17:25Z XXX followers, XXX engagements


"$CYBE $CYBHF National Security Expert Joins Board Access to 221000 Defense Companies Redefining Cybersecurity with AI Solutions $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978889039638884421) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T18:21Z XXX followers, XX engagements


"$CYBN CYB004 on track with anxiety Phase X Enrollment completion driving progress Path to commercial readiness strengthening $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978890064311562253) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T18:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins board for strategic growth 221K defense and 600K healthcare firms targeted AI-driven platform leads cybersecurity innovation $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978904074218066412) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T19:21Z XXX followers, XX engagements


"$CYBN CYB003 enrollment completion announced Phase X depression trial fully enrolled Psychedelic pipeline advancing towards data $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978905124589191383) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T19:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins Board boosting strategic direction Potential $100M annual revenue opportunity Disrupting SME cybersecurity with AI-driven compliance $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978919192708473266) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T20:21Z XXX followers, XX engagements


"$CYBN CYB004 anxiety trial making steady progress Phase X program actively enrolling patients Advancing therapeutic options in mental health $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978920188859809837) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T20:25Z XXX followers, XXX engagements


"$CYBE $CYBHF New strategic partnership with U.S. resellers Targeting 221K defense firms projected $100M revenue Disrupting with AI compliance and no-budget insurance $CRWD $PANW $FTNT $ZS"  
[X Link](https://x.com/PsychedStocks/status/1978934272640651514) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T21:21Z XXX followers, XX engagements


"$CYBN First patient dosed in CYB005 AUD trial Early-stage alcohol use disorder treatment Innovative addiction therapy approach $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978935402430910563) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T21:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Innovative cybersecurity for SMEs with CMMC solutions $100M revenue growth potential with AI-enabled tech Disrupting defense sector with risk mitigation tools $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979145671627117038) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T11:21Z XXX followers, XX engagements


"$CYBN CYB003 full enrollment in Phase X achieved Depression trial timeline on track for 2025 data Psychedelic therapies advancing FDA milestones $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1979146703287492662) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T11:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins board for defense focus Billion-dollar defense sector opportunity Transforming cyber insurance market $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979160763022319706) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T12:21Z XXX followers, XX engagements


"$CYBN CYB004 Phase X anxiety trial completion announced Key milestone achieved in mental health treatment pathway Expanding therapeutic opportunities in psychedelics $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1979161833287156020) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T12:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Innovative AI platform accelerates compliance XX% organizations vulnerable with $10M cost Driving change in SME cybersecurity insurance $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979175851544482187) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T13:21Z XXX followers, XX engagements


"$CYBN CYB003 Phase X depression trial hits enrollment target Dosing completion ahead of anticipated timeline Psychedelic therapies continue gaining regulatory traction $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1979176921238806756) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T13:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins board enhancing national security stance Targets 140K defense contractors with CMMC compliance Transformative cybersecurity shift for SMEs $CRWD $PANW $FTNT $ZRAN"  
[X Link](https://x.com/PsychedStocks/status/1979190955338027342) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T14:21Z XXX followers, XX engagements


"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1979192024596095259) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T14:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait bolsters Board strategic focus $1B+ potential addressable market Disrupting U.S. defense with AI cybersecurity $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979206043721662770) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T15:21Z XXX followers, XX engagements


"$CYBN Positive market movement today with $CYBN Investor interest driving upward momentum Psychedelic sector sentiment improving $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1979207161352794296) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T15:25Z XXX followers, XX engagements


"$CYBE $CYBHF Strategic reseller pact with US Govt Driving exponential sales growth Disrupting SME cybersecurity market $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979221141471256609) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T16:21Z XXX followers, XX engagements


"$CYBN Q3 results show pathway to profitability Partnership milestone payment received Clinical stage monetization model emerging $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1979222171193954356) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T16:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins Board Targets 221K US defense firms Innovative AI compliance solutions $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979236213887242614) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T17:21Z XXX followers, XX engagements


"$CYBN CYB004 anxiety trial first patient dosed Advancing towards critical Phase X milestone Multiple shots on goal strategy strengthening $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1979237248898846904) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T17:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Accepts national security expert Scott Tait to board Targeting 221K US defense firms $1B potential market AI-driven risk mitigation revolutionizing cybersecurity $CRWD $FTNT $CYBR $ZS"  
[X Link](https://x.com/PsychedStocks/status/1979251421166944517) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T18:21Z XXX followers, XX engagements


"$CYBN CYB004 reports positive Phase X anxiety data Strengthens pipeline with promising results Regulatory pathway now clearer for CYB004 $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1979252390369841175) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T18:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Drives growth through CMMC compliance High-impact market potential $1B opportunity Disrupting cybersecurity with unique insurance model $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979266438788513983) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T19:21Z XXX followers, XX engagements


"$CYBE $CYBHF National security expert joins board Expanding risk mitigation reach AI-driven compliance transformation $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979281568414806345) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T20:21Z XXX followers, XX engagements


"$CYBE $CYBHF Scott Tait joins Board bolstering security expertise 140K U.S. defense firms meeting quick compliance needs Innovating SMEs' defense with AI solutions $CRWD $FTNT $PANW $ZS"  
[X Link](https://x.com/PsychedStocks/status/1979296663270232521) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T21:21Z XXX followers, XX engagements